Comparing the Occurrence of Healthcare-Associated Infections in Patients with and Without COVID-19 Hospitalized During the Pandemic: A 16-Month Retrospective Cohort Study in a Hospital Intensive Care Unit

The COVID-19 pandemic has increased the healthcare-associated infection (HAI) risk in intensive care unit (ICU) patients. However, a comparison between patients with and without COVID-19 in terms of HAI incidence has been rarely explored. In this study, we characterized the occurrence of HAI among patients with and without COVID-19 admitted to the ICU of the Umberto I hospital of Rome during the first 16 months of the pandemic and also identified risk factors for HAI acquisition. Patients were divided into four groups according to their ICU admission date. A multivariable conditional risk set regression model for multiple events was constructed for each admission period. Adjusted hazard ratios and 95% confidence intervals were calculated. Overall, 352 COVID-19 and 130 non-COVID-19 patients were included, and a total of 361 HAIs were recorded. We found small differences between patients with and without COVID-19 in the occurrence and type of HAI, but the infections in the two cohorts mostly involved different microorganisms. The results indicate that patient management was likely an important factor influencing the HAI occurrence during the pandemic. Effective prevention and control strategies to reduce HAI rates should be implemented.

Citing Articles

Incidence and Predictors of Healthcare-Associated Infections in Patients Admitted to a Temporary Intensive Care Unit during the COVID-19 Pandemic Waves: A Two-Year (2021-2023) Retrospective Cohort Study in Rome, Italy.

Sciurti A, Baccolini V, Ceparano M, Isonne C, Migliara G, Iera J Antibiotics (Basel). 2024; 13(9).

PMID: 39335015 PMC: 11428387. DOI: 10.3390/antibiotics13090842.

Predicting early appropriate therapy for patients infected by carbapenem-resistant Gram-negative pathogens in intensive care units in Italy.

Bassetti M, Monti G, Santerre Henriksen A, Longshaw C Antimicrob Resist Infect Control. 2024; 13(1):91.

PMID: 39183351 PMC: 11345987. DOI: 10.1186/s13756-024-01452-y.

Pneumonia Characteristics in an Intensive Care Unit Setting during and after the COVID-19 Pandemic-A Single-Center Prospective Study.

Sleziak J, Pilarczyk K, Matysiak M, Duszynska W J Clin Med. 2024; 13(10).

PMID: 38792365 PMC: 11121790. DOI: 10.3390/jcm13102824.

Evaluation of the impact of COVID-19 pandemic on hospital-acquired infections in a tertiary hospital in Malaysia.

Ismaeil R, Fata Nahas A, Kamarudin N, Abubakar U, Mat-Nor M, Mohamed M BMC Infect Dis. 2023; 23(1):779.

PMID: 37946158 PMC: 10636815. DOI: 10.1186/s12879-023-08770-3.

Central Line Associated Bloodstream Infections in Critical Ill Patients during and before the COVID-19 Pandemic.

Hlinkova S, Moraucikova E, Lesnakova A, Strzelecka A, Littva V Healthcare (Basel). 2023; 11(17).

PMID: 37685449 PMC: 10487552. DOI: 10.3390/healthcare11172415.

References

Bardi T, Pintado V, Gomez-Rojo M, Escudero-Sanchez R, Azzam Lopez A, Diez-Remesal Y . Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome. Eur J Clin Microbiol Infect Dis. 2021; 40(3):495-502. PMC: 7778834. DOI: 10.1007/s10096-020-04142-w. View

McCabe R, Schmit N, Christen P, DAeth J, Lochen A, Rizmie D . Adapting hospital capacity to meet changing demands during the COVID-19 pandemic. BMC Med. 2020; 18(1):329. PMC: 7565725. DOI: 10.1186/s12916-020-01781-w. View

Venier A, Leroyer C, Slekovec C, Talon D, Bertrand X, Parer S . Risk factors for Pseudomonas aeruginosa acquisition in intensive care units: a prospective multicentre study. J Hosp Infect. 2014; 88(2):103-8. DOI: 10.1016/j.jhin.2014.06.018. View

Angelozzi A, Caminada S, Dorelli B, Sindoni A, Baccolini V, Di Paolo C . Knowledge, attitude, barriers, professional behaviour and possible interventions: a survey on healthcare-associated infections among the healthcare workers of an intensive care unit in a large teaching hospital in Rome. Ann Ig. 2021; 33(6):628-643. DOI: 10.7416/ai.2021.2461. View

Rouyer M, Strazzulla A, Youbong T, Tarteret P, Pitsch A, de Pontfarcy A . Ventilator-Associated Pneumonia in COVID-19 Patients: A Retrospective Cohort Study. Antibiotics (Basel). 2021; 10(8). PMC: 8388913. DOI: 10.3390/antibiotics10080988. View

Graham J, Olchowski A, Gilreath T . How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev Sci. 2007; 8(3):206-13. DOI: 10.1007/s11121-007-0070-9. View

McMullen K, Smith B, Rebmann T . Impact of SARS-CoV-2 on hospital acquired infection rates in the United States: Predictions and early results. Am J Infect Control. 2020; 48(11):1409-1411. PMC: 7329659. DOI: 10.1016/j.ajic.2020.06.209. View

Kubin C, McConville T, Dietz D, Zucker J, May M, Nelson B . Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections. Open Forum Infect Dis. 2021; 8(6):ofab201. PMC: 8135866. DOI: 10.1093/ofid/ofab201. View

Tyrrell C, Mytton O, Gentry S, Thomas-Meyer M, Allen J, Narula A . Managing intensive care admissions when there are not enough beds during the COVID-19 pandemic: a systematic review. Thorax. 2020; 76(3):302-312. PMC: 7892390. DOI: 10.1136/thoraxjnl-2020-215518. View

10.

Rodriguez-Acelas A, Almeida M, Engelman B, Canon-Montanez W . Risk factors for health care-associated infection in hospitalized adults: Systematic review and meta-analysis. Am J Infect Control. 2017; 45(12):e149-e156. DOI: 10.1016/j.ajic.2017.08.016. View

11.

Migliara G, Di Paolo C, Barbato D, Baccolini V, Salerno C, Nardi A . Multimodal surveillance of healthcare associated infections in an intensive care unit of a large teaching hospital. Ann Ig. 2019; 31(5):399-413. DOI: 10.7416/ai.2019.2302. View

12.

Ong C, Farhanah S, Linn K, Tang Y, Poon C, Lim A . Nosocomial infections among COVID-19 patients: an analysis of intensive care unit surveillance data. Antimicrob Resist Infect Control. 2021; 10(1):119. PMC: 8358905. DOI: 10.1186/s13756-021-00988-7. View

13.

Askarian M, Yadollahi M, Assadian O . Point prevalence and risk factors of hospital acquired infections in a cluster of university-affiliated hospitals in Shiraz, Iran. J Infect Public Health. 2012; 5(2):169-76. DOI: 10.1016/j.jiph.2011.12.004. View

14.

Migliara G, Baccolini V, Isonne C, Cianfanelli S, Di Paolo C, Mele A . Prior Antibiotic Therapy and the Onset of Healthcare-Associated Infections Sustained by Multidrug-Resistant in Intensive Care Unit Patients: A Nested Case-Control Study. Antibiotics (Basel). 2021; 10(3). PMC: 8000440. DOI: 10.3390/antibiotics10030302. View

15.

Baker M, Sands K, Huang S, Kleinman K, Septimus E, Varma N . The Impact of Coronavirus Disease 2019 (COVID-19) on Healthcare-Associated Infections. Clin Infect Dis. 2021; 74(10):1748-1754. PMC: 8385925. DOI: 10.1093/cid/ciab688. View

16.

Tan E, Song J, Deane A, Plummer M . Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU: A Systematic Review and Meta-analysis. Chest. 2020; 159(2):524-536. PMC: 7557272. DOI: 10.1016/j.chest.2020.10.014. View

17.

Bonnet N, Martin O, Boubaya M, Levy V, Ebstein N, Karoubi P . High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective study. Ann Intensive Care. 2021; 11(1):37. PMC: 7910764. DOI: 10.1186/s13613-021-00825-5. View

18.

Blonz G, Kouatchet A, Chudeau N, Pontis E, Lorber J, Lemeur A . Epidemiology and microbiology of ventilator-associated pneumonia in COVID-19 patients: a multicenter retrospective study in 188 patients in an un-inundated French region. Crit Care. 2021; 25(1):72. PMC: 7891465. DOI: 10.1186/s13054-021-03493-w. View

19.

De Filippis G, Cavazzana L, Gimigliano A, Piacenza M, Vimercati S . Covid-19 pandemic: A frontline hospital reorganization to cope with therapeutic and diagnostic emergency. Pharmacol Res. 2020; 161:105160. PMC: 7428776. DOI: 10.1016/j.phrs.2020.105160. View

20.

Siegel J, Rhinehart E, Jackson M, Chiarello L . Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007; 35(10 Suppl 2):S165-93. DOI: 10.1016/j.ajic.2007.10.006. View